Find a Clinical Trial

Find a Clinical Trial

Search by practice name, trial titles, indicators and specific disease types.

Prostate Cancer

Clinical Trial at: Minnesota Oncology - Edina

CYCLONE 2: A Phase 2, Randomized, Double-blind, Placebo-Controlled Study of Abiraterone Acetate Plus Prednisone with or without Abemaciclib in Patients with Metastatic Castration-Resistant Prostate Cancer (I3Y-MC-JPCM)

  • Details

ClinicalTrials.gov ID: NCT03706365
Diagnosis Type: NA
USOR Number: 18128

  • Practice Details

6545 France Avenue, Suite 210
Edina, Minnesota 55435
552.27 mi. away
P: (952) 928-2900

More Details View Practice Page

Bladder Cancer

Clinical Trial at: Minnesota Oncology - Edina

Biomarker Study to Identify Subjects with Advanced Urothelial Cancer and Fibroblast Growth Factor Receptor Gene Aberrations (42756493BLC0002)

  • Details

ClinicalTrials.gov ID: NCT03955913
Diagnosis Type: NA
USOR Number: 19032

  • Practice Details

6545 France Avenue, Suite 210
Edina, Minnesota 55435
552.27 mi. away
P: (952) 928-2900

More Details View Practice Page

Urothelial Cancer

Clinical Trial at: Minnesota Oncology - Edina

Biomarker Study to Identify Subjects with Advanced Urothelial Cancer and Fibroblast Growth Factor Receptor Gene Aberrations (42756493BLC0002)

  • Details

ClinicalTrials.gov ID: NCT03955913
Diagnosis Type: NA
USOR Number: 19032

  • Practice Details

6545 France Avenue, Suite 210
Edina, Minnesota 55435
552.27 mi. away
P: (952) 928-2900

More Details View Practice Page

Lung Cancer

Clinical Trial at: Minnesota Oncology - Edina

20190009: A Phase 3 Multicenter, Randomized, Open Label, Active-controlled, Study of AMG 510 Versus Docetaxel for the Treatment of Previously Treated Locally Advanced and Unresectable or Metastatic NSCLC Subjects with Mutated KRAS p.G12C

  • Details

ClinicalTrials.gov ID: NCT04303780
Diagnosis Type: NA
USOR Number: 19143

  • Practice Details

6545 France Avenue, Suite 210
Edina, Minnesota 55435
552.27 mi. away
P: (952) 928-2900

More Details View Practice Page

Leukemia

Clinical Trial at: Minnesota Oncology - Edina

A Phase 3b, Single-Arm, Multicenter Open-Label Study of Venetoclax in Combination with Azacitidine or Decitabine in an Outpatient Setting in AML Patients Ineligible for Intensive Chemotherapy (M19-072)

  • Details

ClinicalTrials.gov ID: NCT03941964
Diagnosis Type: AML
USOR Number: 18168

  • Practice Details

6545 France Avenue, Suite 210
Edina, Minnesota 55435
552.27 mi. away
P: (952) 928-2900

More Details View Practice Page

Prostate Cancer

Clinical Trial at: Minnesota Oncology - Edina

A Phase 3 Randomized, Placebo-controlled, Double-blind Study of Niraparib in Combination with Abiraterone Acetate and Prednisone Versus Abiraterone Acetate and Prednisone for Treatment of Subjects with Metastatic Prostate Cancer(64091742PCR3001)

  • Details

ClinicalTrials.gov ID: NCT03748641
Diagnosis Type: NA
USOR Number: 18103

  • Practice Details

6545 France Avenue, Suite 210
Edina, Minnesota 55435
552.27 mi. away
P: (952) 928-2900

More Details View Practice Page

Gall Bladder Cancer

Clinical Trial at: Minnesota Oncology - Edina

A Phase 3 Multicenter, Open-Label, Randomized, Controlled Study of Oral Infigratinib versus Gemcitabine with Cisplatin in Subjects with Advanced/Metastatic or Inoperable Cholangiocarcinoma with FGFR2 Gene Fusions/Translocations: The PROOF Trial (QBGJ398-301)

  • Details

ClinicalTrials.gov ID: NCT03773302
Diagnosis Type: NA
USOR Number: 18264

  • Practice Details

6545 France Avenue, Suite 210
Edina, Minnesota 55435
552.27 mi. away
P: (952) 928-2900

More Details View Practice Page

Malignant Adenoma

Clinical Trial at: Minnesota Oncology - Edina

A Phase 1/2 Multiple Expansion Cohort Trial of MRTX849 in Patients with Advanced Solid Tumors with KRAS G12C Mutation (849-001)

  • Details

ClinicalTrials.gov ID: NCT03785249
Diagnosis Type: NA
USOR Number: 19151

  • Practice Details

6545 France Avenue, Suite 210
Edina, Minnesota 55435
552.27 mi. away
P: (952) 928-2900

More Details View Practice Page

Bladder Cancer

Clinical Trial at: Minnesota Oncology - Edina

A Phase 1/2 Multiple Expansion Cohort Trial of MRTX849 in Patients with Advanced Solid Tumors with KRAS G12C Mutation (849-001)

  • Details

ClinicalTrials.gov ID: NCT03785249
Diagnosis Type: NA
USOR Number: 19151

  • Practice Details

6545 France Avenue, Suite 210
Edina, Minnesota 55435
552.27 mi. away
P: (952) 928-2900

More Details View Practice Page

Head and Neck Cancer

Clinical Trial at: Minnesota Oncology - Edina

A Phase 1/2 Multiple Expansion Cohort Trial of MRTX849 in Patients with Advanced Solid Tumors with KRAS G12C Mutation (849-001)

  • Details

ClinicalTrials.gov ID: NCT03785249
Diagnosis Type: NA
USOR Number: 19151

  • Practice Details

6545 France Avenue, Suite 210
Edina, Minnesota 55435
552.27 mi. away
P: (952) 928-2900

More Details View Practice Page

Thyroid Cancer

Clinical Trial at: Minnesota Oncology - Edina

A Phase 1/2 Multiple Expansion Cohort Trial of MRTX849 in Patients with Advanced Solid Tumors with KRAS G12C Mutation (849-001)

  • Details

ClinicalTrials.gov ID: NCT03785249
Diagnosis Type: NA
USOR Number: 19151

  • Practice Details

6545 France Avenue, Suite 210
Edina, Minnesota 55435
552.27 mi. away
P: (952) 928-2900

More Details View Practice Page

Rectal Cancer

Clinical Trial at: Minnesota Oncology - Edina

A Phase 1/2 Multiple Expansion Cohort Trial of MRTX849 in Patients with Advanced Solid Tumors with KRAS G12C Mutation (849-001)

  • Details

ClinicalTrials.gov ID: NCT03785249
Diagnosis Type: NA
USOR Number: 19151

  • Practice Details

6545 France Avenue, Suite 210
Edina, Minnesota 55435
552.27 mi. away
P: (952) 928-2900

More Details View Practice Page

Endometrial Cancer

Clinical Trial at: Minnesota Oncology - Edina

A Phase 1/2 Multiple Expansion Cohort Trial of MRTX849 in Patients with Advanced Solid Tumors with KRAS G12C Mutation (849-001)

  • Details

ClinicalTrials.gov ID: NCT03785249
Diagnosis Type: NA
USOR Number: 19151

  • Practice Details

6545 France Avenue, Suite 210
Edina, Minnesota 55435
552.27 mi. away
P: (952) 928-2900

More Details View Practice Page

Ovarian Cancer

Clinical Trial at: Minnesota Oncology - Edina

A Phase 1/2 Multiple Expansion Cohort Trial of MRTX849 in Patients with Advanced Solid Tumors with KRAS G12C Mutation (849-001)

  • Details

ClinicalTrials.gov ID: NCT03785249
Diagnosis Type: NA
USOR Number: 19151

  • Practice Details

6545 France Avenue, Suite 210
Edina, Minnesota 55435
552.27 mi. away
P: (952) 928-2900

More Details View Practice Page

Bone Mets

Clinical Trial at: Minnesota Oncology - Edina

A Phase 1/2 Multiple Expansion Cohort Trial of MRTX849 in Patients with Advanced Solid Tumors with KRAS G12C Mutation (849-001)

  • Details

ClinicalTrials.gov ID: NCT03785249
Diagnosis Type: NA
USOR Number: 19151

  • Practice Details

6545 France Avenue, Suite 210
Edina, Minnesota 55435
552.27 mi. away
P: (952) 928-2900

More Details View Practice Page

Kaposi's Sarcoma

Clinical Trial at: Minnesota Oncology - Edina

A Phase 1/2 Multiple Expansion Cohort Trial of MRTX849 in Patients with Advanced Solid Tumors with KRAS G12C Mutation (849-001)

  • Details

ClinicalTrials.gov ID: NCT03785249
Diagnosis Type: NA
USOR Number: 19151

  • Practice Details

6545 France Avenue, Suite 210
Edina, Minnesota 55435
552.27 mi. away
P: (952) 928-2900

More Details View Practice Page

Urothelial Cancer

Clinical Trial at: Minnesota Oncology - Edina

A Phase 1/2 Multiple Expansion Cohort Trial of MRTX849 in Patients with Advanced Solid Tumors with KRAS G12C Mutation (849-001)

  • Details

ClinicalTrials.gov ID: NCT03785249
Diagnosis Type: NA
USOR Number: 19151

  • Practice Details

6545 France Avenue, Suite 210
Edina, Minnesota 55435
552.27 mi. away
P: (952) 928-2900

More Details View Practice Page

Renal Cancer

Clinical Trial at: Minnesota Oncology - Edina

A Phase 1/2 Multiple Expansion Cohort Trial of MRTX849 in Patients with Advanced Solid Tumors with KRAS G12C Mutation (849-001)

  • Details

ClinicalTrials.gov ID: NCT03785249
Diagnosis Type: NA
USOR Number: 19151

  • Practice Details

6545 France Avenue, Suite 210
Edina, Minnesota 55435
552.27 mi. away
P: (952) 928-2900

More Details View Practice Page

Esophageal Cancer

Clinical Trial at: Minnesota Oncology - Edina

A Phase 1/2 Multiple Expansion Cohort Trial of MRTX849 in Patients with Advanced Solid Tumors with KRAS G12C Mutation (849-001)

  • Details

ClinicalTrials.gov ID: NCT03785249
Diagnosis Type: NA
USOR Number: 19151

  • Practice Details

6545 France Avenue, Suite 210
Edina, Minnesota 55435
552.27 mi. away
P: (952) 928-2900

More Details View Practice Page

Pancreatic Cancer

Clinical Trial at: Minnesota Oncology - Edina

A Phase 1/2 Multiple Expansion Cohort Trial of MRTX849 in Patients with Advanced Solid Tumors with KRAS G12C Mutation (849-001)

  • Details

ClinicalTrials.gov ID: NCT03785249
Diagnosis Type: NA
USOR Number: 19151

  • Practice Details

6545 France Avenue, Suite 210
Edina, Minnesota 55435
552.27 mi. away
P: (952) 928-2900

More Details View Practice Page

Pages